The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Augmentation of the Restless Legs Syndrome With Carbidopa/Levodopa
Abstract
Dopaminergic agents and carbidopa/levodopa have become the preferred treatment for both the restless legs (RL) syndrome and for periodic limb movements in sleep (PLMS). For once-nightly treatments with carbidopa/ levodopa, a problem with morning end-of-dose rebound increases in leg movements has been reported to occur in the about one-fourth of the patients. In our clinical studies a previously unreported but far more significant problem of markedly augmented RL symptoms occurred in the afternoon and the evening prior to taking the next nightly dose. A systematic prospective evaluation of this augmentation in 46 consecutive patients treated with carbidopa/ levodopa for RL syndrome or PLMS disorder found this augmentation to be the major adverse effect of treatment. Augmentation occurred for 31% of PLMS patients and 82% of all RL patients. It was greater for subjects with more severe RL symptoms and for patients on higher doses (> or = 50/200 mg carbidopa/levodopa) but was unrelated to gender, age or baseline severity of PLMS. This augmentation was severe enough to require medication change for 50% of the RL patients and 13% of PLMS patients. Augmentation resolved with cessation of the medication and could be minimized by keeping the dose low.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The International Classification of Sleep Disorders: Diagnostic and Coding Manual
(1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-115-5-413_1 · Cited by 2,413
Ekbom, K. A. (1960) · Neurology · doi:10.1212/wnl.10.9.868 · Cited by 841
Periodic movements in sleep (nocturnal myoclonus): Relation to sleep disorders
Coleman Phd, R. M., Pollak, C. P., & Weitzman, E. D. (1980) · Annals of Neurology · doi:10.1002/ana.410080413 · Cited by 340
Kaplan, P. W., Allen, R. P., Buchholz, D. W., & Walters, J. K. (1993) · Sleep · doi:10.1093/sleep/16.8.717 · Cited by 185
Self-citationA double‐blind randomized crossover trial of bromocriptine and placebo in restless legs syndrome
Walters, A. S., Hening, W. A., Kavey, N., Chokroverty, S., & Gidro‐Frank, S. (1988) · Annals of Neurology · doi:10.1002/ana.410240318 · Cited by 175
Restless Legs Syndrome Treatment with Dopaminergic Drugs
Akpinar, L. (1987) · Clinical Neuropharmacology · doi:10.1097/00002826-198702000-00007 · Cited by 136
Effects of lisuride and LSD on cerebral monoamine systems and hallucinosis
Pieri, L., Keller, H. H., Burkard, W. P., & Prada, M. D. (1978) · Nature · doi:10.1038/272278a0 · Cited by 128
Dopaminergic treatment of restless legs and rebound phenomenon
Guilleminault, C., Cetel, M., & Philip, P. (1993) · Neurology · doi:10.1212/wnl.43.2.445 · Cited by 123
Becker, P. M., Jamieson, A. O., & Brown, W. D. (1993) · SLEEP · doi:10.1093/sleep/16.8.713 · Cited by 108
Mereu, G., Casu, M., & Gessa, G. L. (1983) · Brain Research · doi:10.1016/0006-8993(83)91125-3 · Cited by 75
von Scheele, C. (1986) · The Lancet · doi:10.1016/s0140-6736(86)92135-5 · Cited by 70
SCH23390 effects on apomorphine-induced responses of nigral dopaminergic neurons.
Napier, T. C., Givens, B. S., Schulz, D. W., Bunney, B. S., Breese, G. R., & Mailman, R. B. (1986) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)38980-9 · Cited by 46
Sabatini, U., Rascol, O., Celsis, P., et al. (1991) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1991.tb03886.x · Cited by 22
Cited by
Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology
Allen, R. P., Picchietti, D., Hening, W. A., Trenkwalder, C., Walters, A. S., & Montplaisi, J. (2003) · Sleep Medicine · doi:10.1016/s1389-9457(03)00010-8 · Cited by 2,900
Self-citationAllen, R. P., Picchietti, D. L., Garcia-Borreguero, D., Ondo, W. G., Walters, A. S., Winkelman, J. W., Zucconi, M., Ferri, R., Trenkwalder, C., & Lee, H. B. (2014) · Sleep Medicine · doi:10.1016/j.sleep.2014.03.025 · Cited by 1,609
Self-citationThe scientific and clinical basis for the treatment of Parkinson disease (2009)
Olanow, C. W., Stern, M. B., & Sethi, K. (2009) · Neurology · doi:10.1212/wnl.0b013e3181a1d44c · Cited by 908
HENING, W. (2004) · Sleep Medicine · doi:10.1016/j.sleep.2004.03.006 · Cited by 630
A Genetic Risk Factor for Periodic Limb Movements in Sleep
Stefansson, H., Rye, D. B., Hicks, A., Petursson, H., Ingason, A., Thorgeirsson, T. E., Palsson, S., Sigmundsson, T., Sigurdsson, A. P., Eiriksdottir, I., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa072743 · Cited by 630
Metadata
- Authors
- Allen, R. P., & Earley, C. J.
- Venue
- Sleep
- Publisher
- Oxford University Press (OUP)
- Published
- 1996-04
- Volume
- 19
- Issue
- 3
- Pages
- 205-213
- ISSN
- 0161-8105 (ISSN-L)
- 1550-9109
- OpenAlex
- W83552848
- Cited by
- 451
- References
- 13
- FWCI
- 8.00
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.